2009
DOI: 10.1016/j.healun.2009.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Implantable Defibrillators and Cardiac Resynchronization Therapy in Heart Transplant Recipients: Results of a National Survey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
1
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(25 citation statements)
references
References 15 publications
0
22
1
2
Order By: Relevance
“…Notwithstanding the current guidelines that recommend pacemaker for syncope after HT, such patients may be at risk of serious ventricular arrhythmia (see below). If detailed evaluation identifies no reversible cause, ICD implantation may be considered because of the possibility of SCD, although this is not clearly supported by evidence …”
Section: Arrhythmias: Manifestations and Managementmentioning
confidence: 99%
See 1 more Smart Citation
“…Notwithstanding the current guidelines that recommend pacemaker for syncope after HT, such patients may be at risk of serious ventricular arrhythmia (see below). If detailed evaluation identifies no reversible cause, ICD implantation may be considered because of the possibility of SCD, although this is not clearly supported by evidence …”
Section: Arrhythmias: Manifestations and Managementmentioning
confidence: 99%
“…Heart transplantation (HT) has significantly altered the treatment paradigm for end‐stage heart disease. With current surgical techniques and postoperative immunosuppression, 1‐year survival after HT is ≈90%, 5‐year survival is ≈70%, and median survival exceeds 10 years …”
Section: Introductionmentioning
confidence: 99%
“…It also adds to the existing literature of CRT in OHTx patients. 3,4 In the HTx population, LV systolic dysfunction and heart failure often relates to severe CAV, which portends a poor prognosis and confers a high risk of sudden death. 7,8 The use of angiotensin-converting enzyme inhibitors, ␤-blockers, and implantable defibrillators remains largely empiric in these patients, and consideration for repeat HTx has historically been the only viable option.…”
Section: Discussionmentioning
confidence: 99%
“…2 By comparison, experience with CRT in OHTx recipients is marked by a paucity of published experience. Available data suggest that CRT is used infrequently in these patients, 3 and only one previously published brief report 4 has detailed successful CRT use in an OHTx recipient. Indications for CRT in transplant recipients therefore remain poorly defined.…”
Section: Introductionmentioning
confidence: 99%
“…Ряд авторов, сравнивая две методики трансплантации сердца, также получили результаты, согласно которым при бикавальной методике зна-чительно реже наблюдаются различные виды арит-мий [33,34]. Была также выявлена положительная связь между частотой возникновения нарушений ритма и выявлением недостаточности обоих атрио-вентрикулярных клапанов [35].…”
Section: хирургическая методика трансплантации сердцаunclassified